Log in to save to my catalogue

Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin

Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7316741

Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin

About this item

Full title

Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2020-06, Vol.10 (1), p.10345-10345, Article 10345

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Pulmonary arterial hypertension (PAH) is a progressive fatal disease caused by pulmonary arterial remodeling. Midkine regulates cell proliferation and migration, and it is induced by hypoxia, but its roles in pulmonary arterial remodeling remain unclear. Serum midkine levels were significantly increased in PAH patients compared with control patient...

Alternative Titles

Full title

Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7316741

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7316741

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-020-67217-w

How to access this item